Results 131 to 140 of about 40,304 (164)

Beyond Surveillance Mutations: Long-Term Trends and Clinical Relevance of Transmitted HIV Drug Resistance in Spain (2007-2023). [PDF]

Open Forum Infect Dis
Muñoz Báez P, Illescas López M, de Salazar A, Falces Romero I, Pinto A, Portilla I, Masiá M, Peraire J, Alemán Valls MR, Sanchiz M, Iborra A, Baza B, Aguilera A, Olalla J, Espinosa N, Iribarren JA, Gisbert L, Imaz A, Montero M, Navarro Marcotegui M, Suárez-García I, Riera M, Pérez Elias MJ, Galán JC, García Fraile LJ, Sanz J, Ibarra Ugarte S, Bernal E, Blanco JR, Navarro G, Martínez O, Viciana Ramos MI, Mohamen-Balghata MO, Delgado E, Thompson MM, Moreno C, CoRIS C, Fuentes A, García F.   +38 more
europepmc   +1 more source

Anti-HIV-1 Activity of the Integrase Strand Transfer Inhibitor ACC017. [PDF]

Viruses
Ma MD, Luo RH, Li CY, Huang GC, Long XY, He FY, Yang LM, Fu HL, Zheng YT.   +8 more
europepmc   +1 more source

A new family of rolling-circle replication endonucleases widespread in archaeal viruses and plasmids. [PDF]

Nucleic Acids Res
Wang Y, Duan Z, Chen Z, Li S, Chen H, Chen J, Wang Y, Wang J, An K, Xiang J, Du S, Liu Y, Krupovic M, Chen X.   +13 more
europepmc   +1 more source

Gene-sized editing for the therapy of genetic diseases. [PDF]

Funct Integr Genomics
Padureanu T, Cocoș R, Matache IM, Bucur O.   +3 more
europepmc   +1 more source

Block-and-Lock Approaches for HIV Cure: Mechanistic Insights, Challenges, and Emerging Role of CPSF6. [PDF]

Int J Mol Sci
Tolomeo M, Cascio A.
europepmc   +1 more source

Plasmid2MC: efficient cell-free generation of high-purity minicircle DNA for genome editing in mammalian cells. [PDF]

Commun Biol
Oliynyk RT, Mahas A, Karpinski E, Church GM.   +3 more
europepmc   +1 more source

Complete genome sequence of the <i>Streptococcus parauberis</i> lytic bacteriophage JYU001. [PDF]

Microbiol Resour Announc
Heo Y-U, Lee J-Y, Kang H-Y, Park J, Nguyen TL, Kim D-H.   +5 more
europepmc   +1 more source

Maintain, not obtain: rethinking HIV care in sub-Saharan Africa in the era of dolutegravir. [PDF]

Front Public Health
Perno CF, Orlando S, Majid NA, Sangare H, Luanga R, Roccucci M, Silaghi LA, Sidumo Z, Brambilla D, Ceffa S, Guidotti G, Ciccacci F.   +11 more
europepmc   +1 more source

In Vitro Pharmacokinetic Properties of MK-2048, a Potent Drug Candidate for HIV Prevention. [PDF]

Viruses
Zheng R, Valicherla GR, Graebing PW, Zhang J, Hillier SL, Rohan LC.   +5 more
europepmc   +1 more source